Rhapsido (remibrutinib) in one screen Rhapsido is an oral Bruton’s tyrosine kinase (BTK) inhibitor approved by the US FDA on 30 September 2025 for chronic spontaneous urticaria (CSU) in adults who stay symptomatic on H1 antihistamines. It is the first…
Reviewed 11 August 2026 · QC/QA and drug regulatory affairs desk Wet Cough Syrups in India: the 2026 Status Check Two things about this category changed in the last twelve months, and neither is visible on a product label. This…
Liquid Orals QA / QC Last updated: August 2026 The short answer A syrup is a solution — the active is fully dissolved in a sweet, viscous, usually sucrose-based vehicle. A suspension is a two-phase system — undissolved solid particles…
Last verified: 8 August 2026 Schedule H is the list of drug substances under the Drugs and Cosmetics Rules, 1945 that may be sold by retail in India only against the prescription of a Registered Medical Practitioner. This page carries…
Consumer guide · India · Updated 2026 Best Cough Syrup in India (2026): What the New Rules Changed, and How to Choose Correctly The honest answer to “which is the best cough syrup in India” is no longer a…
Drugs Rules, 1945 — India Schedule X drugs list — all 16 substances, the XRx label rule and every licence form The short answer Schedule X to the Drugs Rules, 1945 specifies 16 substances — six barbiturates, five CNS stimulants,…
UK market access · For Indian manufacturers MHRA Compliance for Indian Pharma Exporters to the UK A practical roadmap for Indian manufacturers who want to supply the United Kingdom — how MHRA GMP, marketing authorisation, the Responsible Person (import), and…
Reviewed and updated: 12 August 2026. Regulatory status, indications and Indian commercial-availability status change frequently. Verify against the primary sources in the References before making any clinical, procurement or regulatory decision. In brief Datopotamab deruxtecan is a TROP2-directed antibody-drug conjugate…
Last verified: July 2026 If you’re searching for a pharma company in Karnal — to place an order, verify a supplier, scope out a PCD franchise partner, or find a third-party manufacturer — you probably don’t want a history lesson…
Data verified as of June 19, 2026, sourced from the NSE Nifty Pharma Index free-float market capitalisation weightage. Rankings shift as share prices move — this page is maintained and re-checked against live exchange data, not a one-time snapshot. Twenty-three…